LUF6096 (CF-602) is a selective allosteric enhancer of the adenosine A3 receptor, potentiating agonist binding with minimal orthosteric affinity. It has demonstrated cardioprotective efficacy in models of myocardial ischemia/reperfusion injury, supporting its research use in cardiovascular disease and receptor pharmacology studies.